Search Within

Jason Luke

Formats
  1. Journal Article (6)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (4)
  2. Epidemiology and Biostatistics (4)
  3. Melanoma Disease Management Team (4)
  4. Sarcoma Service (4)
  5. Solid Tumor Oncology Division (4)
  6. Health Outcomes Research Group (3)

More Groups

People
  1. Gary Schwartz (8)
  2. Richard Carvajal (4)
  3. Joshua Mirkin (3)
  4. Mark Dickson (3)
  5. Peter Bach (3)
  6. Mary Keohan (2)

More People

Years
  1. 2014 (1)
  2. 2013 (2)
  3. 2012 (4)
  4. 2011 (5)
Publications
  1. Journal of Clinical Oncology (5)
  2. Clinical Cancer Research (2)
  3. Health Affairs (2)
  4. Clinics in Dermatology (1)
  5. European Journal of Cancer (1)
  6. Journal of Oncology Practice (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Project HOPE (2)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma
    Meeting Abstract

    Piperno-Neumann, S.; Kapiteijn, E.; Larkin, J. M. G.; Carvajal, R. D.; Luke, J. J.; Seifert, H.; Roozen, I.; Zoubir, M.; Yang, L.; Choudhury, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase Ib/II study of imatinab and everolimus in patients with PDGFRA plus synovial sarcoma
    Meeting Abstract

    Keohan, M. L.; Tap, W. D.; Dickson, M. A.; D'Angelo, S. P.; Carvajal, R. D.; Gounder, M. M.; Morales, R. E.; Condy, M. M.; Hameed, M.; Ho, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chemotherapy in the management of advanced cutaneous malignant melanoma
    Journal Article

    Luke, J. J.; Schwartz, G. K.
    Clinics in Dermatology (2013)

    Fulltext@MSK | Save
  • Circulating VEGF levels as a biomarker to clinical benefit to PTC299, the first inhibitor of VEGF synthesis
    Meeting Abstract

    George, C. P.; Luke, J. J.; Winkelman, J.; Cao, Y. T. K. H.; Shakes, L.; Donnelly, K.; Darby, C. H.; Davis, T. W.; Elfring, G. L.; Schwartz, G. K.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: Preclinical investigations and results of a phase I dose-escalation clinical trial
    Journal Article

    Luke, J. J.; D'adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Maki, R. G.; de Stanchina, E.; Musi, E.; Singer, S.; Schwartz, G. K.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Vemurafenib and BRAF inhibition: A new class of treatment for metastatic melanoma
    Journal Article

    Luke, J. J.; Hodi, F. S.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Results of a study of the oral inhibitor PTC299 on tumor VEGF synthesis
    Meeting Abstract

    Luke, J. J.; Callahan, L. A.; Darby, C. H.; Winkelman, M. J.; Barth, J.; Elfring, G. L.; Ogden, A.; Schwartz, G. K.; Gounder, M. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Improving quality and addressing the rising costs of cancer care: Two birds, one stone
    Journal Article

    Luke, J.; Mirkin, J.; Bach, P.
    Journal of Oncology Practice (2011)

    Fulltext@MSK | Save
  • Global reimbursement: The authors reply
    Journal Article

    Bach, P. B.; Mirkin, J. N.; Luke, J. J.
    Health Affairs (2011)

    Fulltext@MSK | Save